Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
PMID 11918944
It is currently appropriate only for patients with severe, refractory disease
Glucagon Receptor Activation The inclusion of glucagon receptor agonism sets Retatrutide apart from all currently approved incretin compounds
Get baseline measurements including weight (weekly average), waist circumference, blood pressure, and bloodwork if possible
Yes, compounded semaglutide and tirzepatide contain the same active ingredients at the same doses as brand-name versions
Talk to a provider today Get a free consultation Find an affordable, caring specialist Many patients experience mild to moderate reactions at their GLP-1 medication injection sites
US$ 21.23
US$ 21.49
US$ 21.16
US$ 28.21
US$ 25.55
US$ 27.96
US$ 22.88
US$ 24.56
